EUCTR2005-000108-15-GB
Active, not recruiting
Not Applicable
Pharmacokinetic and pharmacodynamic properties of oral, intramuscular and intravenous methadone in methadone maintenance patients - ROA-meth
Institute of Psychiatry, Kings College London & South London and Maudsley NHS Trust0 sites10 target enrollmentOctober 3, 2005
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Opioid dependence
- Sponsor
- Institute of Psychiatry, Kings College London & South London and Maudsley NHS Trust
- Enrollment
- 10
- Status
- Active, not recruiting
- Last Updated
- 13 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Inclusion criteria are:
- •(1\)patients who have been in oral methadone maintenance treatment for at least 6 weeks;
- •(2\)on a stable methadone dose between 40 and 200mg for at least 2 weeks;
- •(3\)aged between 18 and 65 years;
- •(4\)a history of having injected drugs in the past 6 months.
- •(5\)able and willing to participate in the study procedures (e.g. no impending prison sentence) and provide informed consent
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1\.2 Adults (18\-64 years) yes
- •F.1\.2\.1 Number of subjects for this age range
Exclusion Criteria
- •The main exclusion criteria are
- •1\.a significant medical condition which may significantly impact upon PK and PD measures, including severe psychiatric comorbidity, severe hepatic or renal disease, pregnancy, chronic pain conditions;
- •2\.concurrent medications which may significantly alter methadone metabolism or response, particularly CYP3A inducers or inhibitors;
- •3\.currently dependent to other substances such as alcohol, benzodiazepines, cocaine, amphetamines or heroin, which may be interfere with study outcome measures;
- •4\.poor venous access, such that cannula insertion and blood sampling is likely to be difficult;
- •5\.currently participating in another research project that may interfere with the present study (or vice versa) or have done so in the past 3 months;
- •6\.not proficient in English to the extent that they cannot understand clinical and research procedures involved in the study.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Not Applicable
Action of amlodipine oral solution in childreHypertensionTherapeutic area: Diseases [C] - Cardiovascular Diseases [C14]EUCTR2013-005323-17-NLErasmus MC
Completed
Not Applicable
Pharmacokinetic and pharmacodynamic properties of amlodipine oral liquid in the pediatric populatiohigh blood pressureHypertension10057166NL-OMON41645Erasmus MC, Universitair Medisch Centrum Rotterdam20
Active, not recruiting
Phase 1
Pharmacokinetic and pharmacodynamic evaluation of linezolid administered intravenously in MRSA-positive, morbidly obese patients with pneumonia.EUCTR2012-005127-33-BEniversity Ghent20
Active, not recruiting
Not Applicable
Pharmacokinetics, pharmacodynamics and safety of a new Leuprolide acetate 22.5 mg depot formulation, when given as palliative treatment to prostate cancer patientsProstate cancerMedDRA version: 8.1Level: LLTClassification code 10007113Term: Cancer of prostateEUCTR2006-005964-24-GBItalfarmaco S.p.A.20
Recruiting
Not Applicable
Study on Pharmacokinetics and Pharmacodynamics of high dose Daptomycin.Infectious DiseaseJPRN-UMIN000017226Keio University20